Boston Scientific acquires remainder of cardiac device maker for $295M

Boston Scientific has pulled the trigger on its option to acquire the remaining stake in Farapulse, a California-based maker of cardiac devices. The company had held a 27% stake in Farapulse since 2014; now, with an upfront payment of $295 million, Boston Scientific is the sole owner of Farapulse. Read More

Read More

Op-ed: A healthy economy includes everyone

To date, the Foundation for Business Equity has worked with dozens of Black and Latinx small-business owners, bringing together strategic-advisory services and growth capital to help businesses grow revenue, create jobs and revitalize communities. Read More

Read More